RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.2950
-0.0283 (-8.75%)
Nov 20, 2026, 12:36 PM EST - Market open
RedHill Biopharma Employees
RedHill Biopharma had 13 employees as of December 31, 2025. The number of employees decreased by 22 or 62.86% compared to the previous year. That makes RedHill Biopharma the 39,698th largest employer in the world and 5,869th in the United States.
Employees
13
Change (1Y)
-22
Growth (1Y)
-62.86%
Revenue / Employee
n/a
Profits / Employee
-$184,462
Market Cap
1.79M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | -22 | -62.86% |
| Dec 31, 2024 | 35 | -18 | -33.96% |
| Dec 31, 2023 | 53 | -60 | -53.10% |
| Dec 31, 2022 | 113 | -88 | -43.78% |
| Dec 31, 2021 | 201 | 19 | 10.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Universe Pharmaceuticals INC | 216 |
| Biofrontera | 94 |
| Sunshine Biopharma | 50 |
| IM Cannabis | 44 |
| cbdMD | 42 |
| Sonoma Pharmaceuticals | 10 |
| Gelteq | 8 |
| PRF Technologies | 7 |
RDHL News
- 3 days ago - RedHill Biopharma (Nasdaq: RDHL) Highlights Strategic Transformation and Expanded Commercial Growth Strategy in Virtual Investor "What This Means" Segment - PRNewsWire
- 18 days ago - RedHill Biopharmaâs RHB-204 shows MAP-killing efficacy in Crohnâs Disease - TheFly
- 18 days ago - Two Leading Labs Confirm RHB-204 MAP-Killing Effect for RedHill's Crohn's Disease Candidate - PRNewsWire
- 4 weeks ago - $2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma - PRNewsWire
- 7 weeks ago - RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results - PRNewsWire
- 7 weeks ago - RedHill Biopharma Earnings release: H1 2026 - Filings
- 2 months ago - RedHill Biopharma Pushes for Growth Securing Rights to Ferringâs $37M Gastrointestinal Drugs Portfolio - TipRanks
- 2 months ago - RedHill Sells its TaliciaÂź H. pylori Drug Business to Apotex in $18M Deal to Fuel Growth - TipRanks